News
-
Cancer Hub to deliver treatment during coronavirus pandemic
3 April 2020
A new approach to cancer care across the capital is being introduced to ensure patients get the lifesaving treatments they need during the Covid-19 pandemic.
Read more -
New network hopes to revolutionise cancer imaging
27 March 2020
Researchers today launched a new cancer network bringing together nine world-leading medical imaging centres across the UK.
Read more -
New hospital for Epsom and St Helier
17 March 2020
The government has committed to invest £500 million to refurbish outdated hospital buildings at both Epsom and St Helier, and to build a new emergency hospital as part of Epsom and St Helier University Hospitals Trust. There is now a public consultation underway to hear feedback from NHS staff, patients and residents on the proposals.
Read more -
Positive breakthrough for new lung cancer drug developed at The Royal Marsden
2 March 2020
Professor Sanjay Popat, consultant medical oncologist at The Royal Marsden NHS Foundation Trust is lead reseracher on new drug developed for lung cancer treatment
Read more -
Major new NIHR grant could help patients with early bowel cancer avoid unnecessary chemotherapy after surgery
18 February 2020
Researchers at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, have been awarded a prestigious £3 million grant by the National Institute for Health Research (NIHR) to investigate whether a blood test can identify which bowel cancer patients will benefit from chemotherapy following surgery.
Read more -
Our response to the NHS consultation into children's cancers
30 January 2020
We believe that a proposal which retains The Royal Marsden’s cancer expertise, life-saving research, modern facilities and accessible location for the population we serve will continue to provide the best clinical outcomes and patient experience.
Read more -
Cervical cancer prevention week 2020
20 January 2020
Cervical screening offers the greatest protection against cervical cancer with smear tests preventing 75% of cervical cancers but the number of women attending cervical screening in the UK is falling.
Read more -
Specialist cancer trust retains its ‘Outstanding’ rating
16 January 2020
The Royal Marsden NHS Foundation Trust has retained its ‘Outstanding’ rating as a Trust and ‘Outstanding’ rating for being well led following an inspection by the Care Quality Commission in September and November 2019.
Read more -
Chief Executive of The Royal Marsden awarded DBE in New Year Honours
27 December 2019
Cally Palmer, Chief Executive of The Royal Marsden NHS Foundation Trust, and National Cancer Director for NHS England and NHS Improvement, has been awarded a DBE for services to cancer medicine.
Read more -
World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery
18 December 2019
A patient at The Royal Marsden is the first in the world to receive chemotherapy assisted by an innovative new technology that uses microscopic clusters of bubbles and liquid droplets to enhance the delivery of drugs to tumours.
Read more